[1]张 凯,任红瑞,陆 林,等.3D血管造影指导下超选择栓塞子宫肌瘤供血动脉14例[J].介入放射学杂志,2024,33(05):533-536.
　ZHANG Kai,REN Hongrui,LU Lin,et al.3D angiography-guided superselective embolization of the supplying arteries of uterine fibroids： preliminary results in 14 patients[J].journal interventional radiology,2024,33(05):533-536.
点击复制

3D血管造影指导下超选择栓塞子宫肌瘤供血动脉14例()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
33
期数:
2024年05
页码:
533-536
栏目:
临床研究
出版日期:
2024-06-03

文章信息/Info

Title:
3D angiography-guided superselective embolization of the supplying arteries of uterine fibroids： preliminary results in 14 patients
作者:
张 凯;  任红瑞;  陆 林;  赵 鑫;  刘香婷;  牛广颖;  张文哲
Author(s):
ZHANG Kai;  REN Hongrui;  LU Lin;  ZHAO Xin;  LIU Xiangting;  NIU Guangying;  ZHANG Wenzhe.
Department of Intervention， Third Affiliated Hospital of Zhengzhou University， Zhengzhou， Henan Province 450052， China
关键词:
【关键词】 子宫肌瘤;  3D血管造影;  供血动脉;  超选择血管栓塞术
文献标志码:
A
摘要:
【摘要】 目的 探讨3D血管造影指导下行超选择子宫肌瘤供血动脉栓塞术治疗子宫肌瘤的效果。 方法 收集在郑州大学第三附属医院接受介入栓塞治疗的14例子宫肌瘤患者临床资料。其中5例子宫动脉3D血管造影明确子宫肌瘤供血动脉来源及走行后，接受微导管超选择栓塞肌瘤供血动脉（A组），9例因肌瘤血供复杂栓塞双侧子宫动脉至主干（B组）。统计分析两组患者术前、术后1年子宫肌瘤可测量最大径线之和，并计算肌瘤缩小率。结果 A组患者术前、术后子宫肌瘤最大径线之和分别为（85.00±43.35） mm、（35.20±25.96） mm，差异有统计学意义（P=0.006）；B组患者术前、术后肌瘤最大径线之和分别为（65.00±12.68） mm、（49.44±24.83） mm，差异无统计学意义（P=0.052）；A、B组间术前、术后肌瘤最大径线之和差异无统计学意义（P=0.366、0.331）。A、B组患者子宫肌瘤中位缩小率分别为62%、25%，差异有统计学意义（P=0.031）。结论 3D血管造影指导下子宫肌瘤供血动脉超选择栓塞治疗子宫肌瘤的效果更佳。

参考文献/References:

［1］ Czarnik M， Cusimano FA， Bahlani S， et al. Embolization for the treatment of large， complex fibroids in an outpatient setting： a report of 2 cases［J］. Radiol Case Rep， 2023， 18： 936- 942.
［2］ Wise LA， Laughlin- Tommaso SK. Epidemiology of uterine fibroids： from menarche to menopause［J］. Clin Obstet Gynecol， 2016， 59： 2- 24.
［3］ 郎景和，陈春林，向 阳，等． 子宫肌瘤及子宫腺肌病子宫动脉栓塞术治疗专家共识［J］． 中华妇产科杂志， 2018， 53：289- 293．
［4］ Sirkeci F， Moss J， Belli AM， et al. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization（UAE） or myomectomy for women with uterine fibroids wishing to avoid hysterectomy： the FEMME randomized controlled trial［J］. Int J Gynaecol Obstet，2023，160：492- 501.
［5］ Akhatova A，Aimagambetova G，Bapayeva G，et al. Reproductive and obstetric outcomes after UAE， HIFU， and TFA of uterine fibroids： systematic review and meta- analysis［J］. Int J Environ Res Public Health， 2023， 20： 4480.
［6］ Pavone D， Clemenza S， Sorbi F， et al. Epidemiology and risk factors of uterine fibroids［J］. Best Pract Res Clin Obstet Gynaecol， 2018， 46： 3- 11.
［7］ Al- Hendy A， Myers ER， Stewart E. Uterine fibroids： burden and unmet medical need［J］. Semin Reprod Med， 2017， 35： 473- 480.
［8］ Lagana AS， Alonso Pacheco L， Tinelli A， et al. Management of asymptomatic submucous myomas in women of reproductive age： a consensus statement from the global congress on hysteroscopy scientific committee［J］. J Minim Invasive Gynecol， 2019， 26： 381- 383.
［9］ Laughlin- Tommaso SK， Lu D， Thomas L， et al. Short- term quality of life after myomectomy for uterine fibroids from the COMPARE- UF Fibroid Registry［J］. Am J Obstet Gynecol， 2020， 222：345.e1- 345.e22.
［10］ Ravina JH，Ciraru- Vigneron N，Bouret JM，et al. Arterial embolisation to treat uterine myomata［J］. Lancet， 1995， 346： 671- 672.
［11］ Psilopatis I， Fleckenstein FN， Collettini F， et al. Short- and long- term evaluation of disease- specific symptoms and quality of life following uterine artery embolization of fibroids［J］. Insights Imaging， 2022， 13： 106.
［12］ Yerezhepbayeva M，Terzic M，Aimagambetova G，et al. Compa- rison of two invasive non- surgical treatment options for uterine myomas： uterine artery embolization and magnetic resonance guided high intensity focused ultrasound- systematic review［J］. BMC Womens Health， 2022， 22： 55.
［13］ Jegaden M，Bleas C，Debras E，et al. Asherman syndrome after uterine artery embolization： a cohort study about surgery mana-gement and fertility outcomes［J］. J Minim Invasive Gynecol， 2023， 30：494- 501.
［14］ Zanolli NC， Bishop KC， Kuller JA， et al. Fibroids and fertility： a comparison of myomectomy and uterine artery embolization on fertility and reproductive outcomes［J］. Obstet Gynecol Surv， 2022， 77： 485- 494.
［15］ Ukybassova T， Terzic M， Dotlic J， et al. Evaluation of uterine artery embolization on myoma shrinkage： results from a large cohort analysis［J］. Gynecol Minim Invasive Ther， 2019， 8： 165- 171.
［16］ Kroncke T. An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus［J］. Br J Radiol， 2022， 96： 20220121.
［17］ 张 凯，任红瑞，马 祯，等． 介入栓塞术在子宫动脉假性动脉瘤中的应用及疗效分析［J］． 介入放射学杂志， 2022， 31：1073- 1077．
［18］ 曾北蓝，陈春林，余莉萍，等． 子宫肌瘤动脉内数字减影血管造影影像学特点及临床意义［J］． 中国实用妇科与产科杂志， 2002， 18：294- 296．
［19］ Pyra K，Szmygin M，Szmygin H，et al. Unilateral uterine artery embolization as a treatment for patients with symptomatic fibroids- experience in a case series［J］. Medicina（Kaunas）， 2022， 58： 1732.

相似文献/References:

[1]姜 曼,赵 卫,姚瑞红,等. 高强度聚焦超声消融治疗子宫肌瘤的临床应用[J].介入放射学杂志,2013,(01):82.
　JIANG Man,ZHAO Wei,YAO Rui? hong,et al. The clinical research of high intensity focused ultrasound therapy for ablating uterine leiomyomas[J].journal interventional radiology,2013,(05):82.
[2]唐世伟,陈 俊,王忠敏,等.介入栓塞术对比手术治疗有症状子宫肌瘤安全性及有效性的meta分析[J].介入放射学杂志,2015,(03):200.
　TANG Shi wei,CHEN Jun,WANG Zhong min,et al.Interventional embolization and surgery for the treatment of symptomatic uterine fibroids： a meta analysis of the safety and effectiveness[J].journal interventional radiology,2015,(05):200.
[3]姚瑞红,赵 卫,姜永能.六氟化硫微泡在高强度聚焦超声治疗子宫肌瘤中的临床价值[J].介入放射学杂志,2016,(10):903.
　YAO Rui- hong,ZHAO Wei,JIANG Yong- neng.The clinical application of sulfur hexafluoride micro- bubbles in treating uterine fibroid with high intensity focused ultrasound[J].journal interventional radiology,2016,(05):903.
[4]鲁仁财,赵 卫,易根发,等.微泡对比剂应用于高强度聚焦超声治疗子宫肌瘤疗效观察 [J].介入放射学杂志,2018,27(01):71.
　LU Rencai,ZHAO Wei,YI Gengfa,et al.The clinical application of microbubble contrast agent in high intensity focused ultrasound treatment for uterine fibroids[J].journal interventional radiology,2018,27(05):71.
[5]易根发,赵 卫,范宏杰,等.不同子宫位置子宫肌瘤的高强度聚焦超声消融效果分析[J].介入放射学杂志,2019,28(03):280.
　YI Genfa,ZHAO Wei,FAN Hongjie,et al.The influence of uterus position on HIFU ablation effect of uterine fibroids[J].journal interventional radiology,2019,28(05):280.
[6]谢璇丞,范宏杰,赵 卫,等.子宫肌瘤介入治疗现状及研究进展[J].介入放射学杂志,2019,28(09):905.
　XIE Xuancheng,FAN Hongjie,ZHAO Wei,et al.Interventional treatment of uterine fibroids： its current situation and research progress[J].journal interventional radiology,2019,28(05):905.
[7]潘文秋,汤蕊嘉,赵 卫,等.高强度聚焦超声治疗子宫肌瘤临床疗效的影响因素[J].介入放射学杂志,2019,28(11):1086.
　PAN Wenqiu,TANG Ruijia,ZHAO Wei,et al.HIFU for the treatment of uterine fibroids: analysis of the factors influencing clinical curative effect[J].journal interventional radiology,2019,28(05):1086.
[8]寸江平,赵卫,范宏杰,等.动态血管模型在六氟化硫微泡联合高强度聚焦超声消融富血供子宫肌瘤中的增效作用[J].介入放射学杂志,2020,29(01):51.
　CUN Jiangping,ZHAO Wei,FAN Hongjie,et al.The synergistic effect of dynamic vascular model in sulfur hexafluoride microbubbles combined with HIFU ablation for fibroids with rich blood supply[J].journal interventional radiology,2020,29(05):51.
[9]邝岚琼,许永华,杨利霞,等.T2WI高信号子宫肌瘤信号强度比值和纹理分析预测聚焦超声消融疗效[J].介入放射学杂志,2022,31(11):1081.
　KUANG Lanqiong,XU Yonghua,YANG Lixia,et al.Application of signal intensity ratio and texture analysis in predicting the efficacy of focused ultrasound ablation for T2WI high signal hysteromyoma[J].journal interventional radiology,2022,31(05):1081.
[10]王艳丽,赵 毅,徐 苗,等.氢吗啡酮自控镇痛应用于子宫肌瘤动脉栓塞术的有效性和安全性[J].介入放射学杂志,2022,31(10):962.
　WANG Yanli,ZHAO Yi,XU Miao,et al.Application of patient-controlled intravenous analgesia using hydromorphone in arterial embolization of uterine fibroids： evaluation of its efficacy and safety[J].journal interventional radiology,2022,31(05):962.

备注/Memo

备注/Memo:
（收稿日期：2023- 04- 22）
（本文编辑：谷 珂）
更新日期/Last Update: 2024-06-03